Login to Your Account

Pair of Failed Studies Prompts Biogen to Drop Arthritis Drug

By Catherine Hollingsworth

Monday, October 13, 2008
Biogen Idec Inc. is stopping development of an investigational arthritis drug due to negative results from two studies that aimed to measure the drug's effectiveness. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription